StempeucelCLI™, mesenchymal stem cells for vascular diseases

StempeucelCLI™ are autologous, ex vivo-expanded bone marrow-derived mesenchymal stem cells used to treat critical limb ischemia and Buerger's disease. They have been found to improve circulation, increase pain-free walking distance, relieve rest pain, heal ischemic ulcer and prevent or decrease amputation rates.